112
Participants
Start Date
July 5, 2025
Primary Completion Date
July 5, 2026
Study Completion Date
July 5, 2026
hormone replacement therapy (HRT) group
Estradiol valerate is initiated at 4 mg/day on day 2 of the menstrual cycle and is adjusted to 8 mg/day based on endometrial thickness. Once the endometrial thickness reaches ≥8 mm, progesterone supplementation is started (400 mg vaginal suppositories twice daily and 50 mg intramuscular injections daily) for 5 days before blastocyst transfer.
Malihe Mahmoudinia
OTHER